Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Catabasis shares fall 50% as cholesterol drug misses study goal
Catabasis shares fall 50% as cholesterol drug misses study goal
Catabasis shares fall 50% as cholesterol drug misses study goal
Submitted by
admin
on June 8, 2016 - 10:33am
Source:
Marketwatch
News Tags:
Catabasis
clinical trials
CAT-2054
Headline:
Catabasis shares fall 50% as cholesterol drug misses study goal
Do Not Allow Advertisers to Use My Personal information
